Prodynorphin gene promoter polymorphism and temporal lobe epilepsy: A meta-analysis

Abstract

Previous studies have reported the association of prodynorphin (PDYN) promoter polymorphism with temporal lobe epilepsy (TLE) susceptibility, but the results remain inconclusive. To further precisely evaluate this association, we performed a meta-analysis. Published studies of TLE and PDYN polymorphism up to February 2015 were identified. Subgroup analysis by TLE subtype was performed. Moreover, sensitivity, heterogeneity, and publication bias were also analyzed. Seven case-control studies were finally included in this meta-analysis with 875 TLE cases and 1426 controls. We did not find synthetic evidence of association between PDYN promoter polymorphism and TLE susceptibility (OR=1.184, 95% CI: 0.873–1.606, P=0.277). Similar results were also obtained in non-familial-risk TLE subgroup. However, in the familial-risk TLE subgroup analysis, a significant association was observed (OR=1.739, 95% CI: 1.154–2.619, P=0.008). In summary, this meta-analysis suggests that PDYN gene promoter polymorphism might contribute to familial-risk TLE.

Keywords

temporal lobe epilepsy / genetics / prodynorphin / polymorphism / meta-analysis

References

[1] EngelJ, PedleyTA. Epilepsy: A Comprehensive Textbook, 2000, Philadelphia, Lippincott Williams & Wilkins

[2] SanderJW, ShorvonSD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry, 1996, 61(5): 433-443 PMCID: 1074036 PMID: 8965090

[3] CavalleriGL, LynchJM, DepondtC, et al. . Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here. Brain, 2005, 128(8): 1832-1840 PMID: 15888540

[4] TejedaHA, ShippenbergTS, HenrikssonR. The dynorphin/ kappa-opioid receptor system and its role in psychiatric disorders. Cell Mol Life Sci, 2012, 69(6): 857-896 PMID: 22002579

[5] HenrikssonR, BäckmanCM, HarveyBK, et al. . PDYN, a gene implicated inbrain/mental disorders, is targeted by REST in the adult human brain. Biochim Biophys Acta, 2014, 1839(11): 1226-1232 PMID: 25220237

[6] BovoG, DianiE, BisulliF, et al. . Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy. Neurosci Lett, 2008, 436(1): 23-26 PMID: 18355961

[7] StögmannE, ZimprichA, BaumgartnerC, et al. . A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol, 2002, 51: 260-263 PMID: 11835385

[8] KauffmanMA, ConsalvoD, GonzalezMD, et al. . Transcriptionally less active prodynorphin promoter alleles are associated with temporal lobe epilepsy: a case-control study and meta-analysis. Disease Markers, 2008, 24(3): 135-140 PMCID: 3850603 PMID: 18334734

[9] SalzmannA, PerroudN, CrespelA, et al. . Candidate genes for temporal lobe epilepsy: a replication study. Neurol Sci, 2008, 29(6): 397-403 PMID: 19066720

[10] TilgenN, RebstockJ, HorvathS, et al. . Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Ann Neurol, 2003, 53(2): 280-281 PMID: 12557303

[11] GambardellaA, MannaI, LabateA, et al. . Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Epilepsia, 2003, 44(9): 1255-1256 PMID: 12919401

[12] HigginsJP, ThompsonSG, DeeksJJ, et al. . Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557-560 PMCID: 192859 PMID: 12958120

[13] MantelN, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 1959, 22(4): 719-748 PMID: 13655060

[14] DerSimonianR, LairdN. Meta-analysis in clinical trials. Control Clin Trials, 1986, 7(3): 177-188 PMID: 3802833

[15] GalbraithRF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med, 1988, 7(8): 889-894 PMID: 3413368

[16] BaxL, IkedaN, FukuiN, et al. . More than numbers: the power of graphs in meta-analysis. Am J Epidemiol, 2009, 169: 249-255 PMID: 19064649

[17] ThakkinstianA, McElduffP, D’EsteC, et al. . A method for meta-analysis of molecular association studies. Stat Med, 2005, 24(9): 1291-1306 PMID: 15568190

[18] MullenB, MuellerleileP, BryantB. Cumulative metaanalysis: A consideration of indicators of sufficiency and stability. Pers Soc Psychol Bull, 2001, 27(11): 1450-1462

[19] BeggCB, MazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994, 50(4): 1088-1101 PMID: 7786990

[20] EggerM, DaveySG, SchneiderM, et al. . Bias in metaanalysis detected by a simple, graphical test. BMJ, 1997, 315: 629-634 PMCID: 2127453 PMID: 9310563

[21] ZondervanKT, CardonLR. The complex interplay among factors that influence allelic association. Nat Rev Genet, 2004, 5: 89-100 PMID: 14735120

[22] SaifyK, SaadatI, SaadatM. Association between VNTR polymorphism inpromoterregion of prodynorphin(PDYN) geneandheroin dependence. Psychiatry Res, 2014, 219(3): 690-692 PMID: 25048760

[23] ZimprichA, KrausJ, WöltjeM, et al. . An allelic variation in the human prodynorphin gene promoter alters stimulusinduced expression. J Neurochem, 2000, 74(2): 472-477 PMID: 10646497

[24] SchwarzerC. 30 years of dynorphins—new insights on their functions in neuropsychiatric diseases. Pharmacol Ther, 2009, 123(3): 353-370 PMCID: 2872771 PMID: 19481570

[25] MergF, FilliolD, UsyninI, et al. . Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor. J Neurochem, 2006, 97(1): 292-301 PMID: 16515546

[26] SolbrigMV, AdrianR, ChangDY, et al. . Viral risk factor for seizures: Pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model. Neurobiol Dis, 2006, 23(3): 612-620 PMID: 16843674

[27] OgitaK, KitayamaT, OkudaH, et al. . Effects of glutathione depletion by 2-cyclohexen-1-one on excitatory amino acids-induced enhancement of activator protein-1 DNA binding in murine hippocampus. J Neurochem, 2001, 76(6): 1905-1915 PMID: 11259509